- Report
- January 2025
- 284 Pages
Global
From €4435EUR$5,000USD£3,851GBP
- Report
- October 2025
- 396 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 382 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 341 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 274 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 390 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 138 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 178 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 294 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 370 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 401 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 479 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 272 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 294 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 271 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 282 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 473 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 383 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 464 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 383 Pages
Global
From €5189EUR$5,850USD£4,505GBP

The Genetic Disease market is a subset of the Genomics market that focuses on the diagnosis, treatment, and prevention of genetic diseases. It is a rapidly growing field, driven by advances in technology and the increasing availability of genetic testing. Companies in this market are developing new treatments and therapies for genetic diseases, as well as diagnostic tests and tools to identify and monitor them. They are also researching ways to prevent genetic diseases from occurring in the first place.
Companies in the Genetic Disease market include Illumina, Thermo Fisher Scientific, BGI, Genomic Health, and Invitae. These companies are developing innovative products and services to help diagnose, treat, and prevent genetic diseases. They are also investing in research and development to further advance the field. Show Less Read more